0001478242-23-000091.txt : 20230921
0001478242-23-000091.hdr.sgml : 20230921
20230921170136
ACCESSION NUMBER: 0001478242-23-000091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230919
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Panagos Constantinos
CENTRAL INDEX KEY: 0001917705
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 231269677
MAIL ADDRESS:
STREET 1: 4280 EMPEROR BLVD
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2400 ELLIS ROAD
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 2400 ELLIS ROAD
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
wk-form4_1695330080.xml
FORM 4
X0508
4
2023-09-19
0
0001478242
IQVIA HOLDINGS INC.
IQV
0001917705
Panagos Constantinos
C/O IQVIA HOLDINGS INC.
2400 ELLIS ROAD
DURHAM
NC
27703
0
1
0
0
See Remarks
0
Common Stock
2023-09-19
4
S
0
19898
208.69
D
14250
D
Common Stock
2023-09-19
4
M
0
2853
95.23
A
17103
D
Common Stock
2023-09-19
4
M
0
7681
131.82
A
24784
D
Common Stock
2023-09-19
4
M
0
11202
161.70
A
35986
D
Common Stock
2023-09-19
4
M
0
4450
183.82
A
40436
D
Common Stock
2023-09-19
4
S
0
7419
208.63
D
33017
D
Common Stock
2023-09-19
4
D
0
18767
208.56
D
14250
D
Stock Appreciation Right
95.23
2023-09-19
4
M
0
2853
0
D
2021-02-08
2028-02-08
Common Stock
2853
0
D
Stock Appreciation Right
131.82
2023-09-19
4
M
0
7681
0
D
2022-02-13
2029-02-13
Common Stock
7681
0
D
Stock Appreciation Right
161.70
2023-09-19
4
M
0
11202
0
D
2023-02-11
2030-02-11
Common Stock
11202
0
D
Stock Appreciation Right
183.82
2023-09-19
4
M
0
4450
0
D
2023-02-09
2031-02-09
Common Stock
4450
2225
D
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.78 to $210.33 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $207.71 to $210.12 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
President, Research & Development Solutions
/s/ Matthew Gilmartin, Attorney-in-Fact for Costa Panagos
2023-09-21